Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery

NCT02855086 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped logistics

Conditions

Brain Neoplasm
Malignant Glioma

Interventions

BIOLOGICAL: Cetuximab
DRUG: Cetuximab-IRDye 800CW
PROCEDURE: Tumor resection

Sponsor

Eben Rosenthal

Collaborators

[object Object]